Detailansicht

Wissensnetz

Person

Sebastian Mayer

Gynäkologe

Name	Sebastian Mayer
Ort	Reutlingen (Geburtsort) Freiburg im Breisgau (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Gynäkologe (charakteristischer Beruf)
Beziehung	Klinik für Frauenheilkunde (2010-)
Datensatztyp	Person
GND-Nummer	112081524X
Datensatz-ID	112081524X
Beteiligt an alle anzeigen Long non‑coding RNA signatures in breast cancer: Properties as biomarkers? Real-world data analysis of CDK4/6 inhibitor therapy - a patient-centric single center study In vitro microRNA expression profile alterations under CDK4/6 therapy in breast cancer Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Sebastian Mayer

Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?

Real-world data analysis of CDK4/6 inhibitor therapy - a patient-centric single center study

In vitro microRNA expression profile alterations under CDK4/6 therapy in breast cancer

Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET

Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection